Search clinical trials for: time window beyond 4.5 hours

Total 10539 results

University of Calgary

Completed

Effect of Prebiotics on Function and Pain in Patients With Osteoarthritis and Obesity

Obesity | Osteo Arthritis Knee

Canada
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Lung Carcinoma | Cigarette Smoking Behavior | Solitary Pulmonary Nodule

United States
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy (CYLINDER)

Diabetic Neuropathies

Russian Federation
Thomas Stauffer Larsen

Completed

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms (DALIAH)

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia

Denmark
Jean-Luc Balligand
University of Oxford; University of Athens; Cliniques universitaires Saint-Luc-... and other collaborators

Active, not recruiting

Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure (Beta3_LVH)

Hypertrophy, Left Ventricular

Belgium, France, Germany, Greece, Italy, Poland, Portugal, United Kingdom
Astellas Pharma Inc
Astellas Pharma Singapore Pte. Ltd.

Completed

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Overactive Bladder

Japan, Korea, Republic of
Swiss Federal Institute of Technology

Completed

Effect of Inulin on Iron Absorption in Humans

Gut Bacteria | Iron Absorption

Switzerland
University of Witwatersrand, South Africa

Completed

Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children (PCV1+1_FU)

Pneumonia | Meningitis

South Africa
Novartis Pharmaceuticals

Completed

A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Relapsing Multiple Sclerosis (RMS)

United States
National Heart, Lung, and Blood Institute (NHLBI)
GlaxoSmithKline; University of Virginia

Completed

Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL

Small Lymphocytic Lymphoma | CLL (Chronic Lymphocytic Leukemia)

United States
University of California, Irvine

Completed

Nicotinamide as an Early Alzheimer's Disease Treatment (NEAT)

Mild Cognitive Impairment | Alzheimer's Disease

United States
Chulalongkorn University

Completed

Impact of Dietary Fiber as Prebiotics on Intestinal Microbiota in Obese Thai Children

Obesity

Thailand
CHU de Quebec-Universite Laval

Completed

Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder (Mirabegron)

Overactive Bladder | Urinary Incontinence
Astellas Pharma Europe B.V.

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Healthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)

Germany
Glycemic Index Laboratories, Inc
DSM Nutritional Products, Inc.

Completed

Effect of Consuming Oat Bran Mixed in Water Before a Meal on Glycemic Responses in Healthy Humans - a Pilot Study

Glucose Intolerance
Genentech, Inc.

Completed

Tenecteplase in Stroke Patients Between 4.5 and 24 Hours (TIMELESS)

THROMBOLYSIS

United States, Canada
Southern California College of Optometry at Marshall...

Recruiting

Eyelid Androgen Treatment in Dry Eye

Aqueous Tear Deficiency | Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)

United States
Ludwig-Maximilians - University of Munich

Active, not recruiting

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC (AIO-KRK-0116)

Metastatic Colorectal Cancer

Germany
Acerus Pharmaceuticals Corporation

Completed

Efficacy of an Intranasal Testosterone Product

Hypogonadism

United States
Rothman Institute Orthopaedics

Completed

A Comparison of Steel and Bioabsorbable Screw Fixation of Lisfranc Foot Injuries (Lisfranc)

Joint Instability

United States
AB Science

Recruiting

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis (MAXIMS)

Progressive Multiple Sclerosis

Spain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
HonorHealth Research Institute
Incyte Corporation

Withdrawn

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Pancreas Cancer

United States
Galderma R&D

Completed

Different Volumes of Durolane in Knee OA

Knee Osteoarthritis

Sweden
Zimmer Biomet

Completed

CM Asia Nail With AS2 Without AS2 （AS2 Study）

Trochanteric Fracture of Femur

Japan
The First Affiliated Hospital of Guangzhou Medical...
Sinotau Pharmaceutical Group

Completed

Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors

Malignant Solid Tumors

China
Wuhan General Hospital of Guangzhou Military Command

Unknown

Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window

Stroke
AstraZeneca

Completed

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5

Asthma
AstraZeneca

Completed

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5

Asthma
Fundación Eduardo Anitua

Active, not recruiting

Randomized Clinical Trial to Evaluate the Predictability of 5.5 mm Dental Implants

Partial-edentulism

Spain
AstraZeneca

Completed

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
Boston Children's Hospital
General Electric

Completed

Oxygen Consumption-based Assessments of Hemodynamics in Neonates Following Congenital Heart Surgery (Oxy-CAHN Study) (Oxy-CAHN)

Hypoplastic Left Heart Syndrome | Transposition of the Great Vessels | Oxygen Consumption Based Assessment of Hemodynamics

United States
AstraZeneca

Completed

Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia (SMARTER)

Asthma

Malaysia
General Hospital of Shenyang Military Region

Recruiting

Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)

Stroke, Ischemic

China
Medical University of South Carolina
National Institute on Deafness and Other Communication Disorders (NIDCD)

Active, not recruiting

Speech Entrainment for Aphasia Recovery (SpARc)

Stroke | Aphasia | Aphasia Non Fluent

United States
King's College Hospital NHS Trust

Recruiting

Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion (TARGET UP)

Critically Ill

United Kingdom
University Hospital Muenster

Completed

Hypoperfusion-hypodensity Mismatch for the Identification of Patients With Stroke Within 4.5 Hours (MissPerfeCT)

Acute Ischemic Stroke

Germany
Carina Biotech Limited

Recruiting

A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer

Colorectal Cancer Metastatic

Australia
Association Francaise pour la Recherche Thermale
University Hospital, Grenoble; Floralis

Completed

Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis

Plaque Psoriasis

France
Huashan Hospital
Shanghai 10th People's Hospital; Shanghai East Hospital; Zhejiang University; The... and other collaborators

Completed

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II (CHABLIS-T II)

Stroke

China
Huashan Hospital
Shanghai 10th People's Hospital; Shanghai East Hospital; The Second Affiliated... and other collaborators

Completed

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase (CHABLIS-T)

Stroke

China
Götz Thomalla, MD
Else Kröner-Fresenius-Stiftung (Foundation); Stroke Imaging Repositoy (STIR); MR Stroke Group

Completed

Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI) (PRE-FLAIR)

Acute Ischemic Stroke

Germany
AB Science

Not yet recruiting

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Spain, France
Professor Michael Bourke

Withdrawn

Barretts oEsophageal Resection With Steroid Therapy Trial (BERST)

Barrett Esophagus | Esophageal Stenosis

Australia
GlaxoSmithKline

Completed

A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.

Dentin Sensitivity

United States
Lee's Pharmaceutical Limited

Unknown

Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense)

Diabetes Mellitus

Hong Kong
General Hospital of Shenyang Military Region

Completed

Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset (INTRECIS)

Ischemic Stroke

China
The First Affiliated Hospital of University of...

Recruiting

Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion

Basilar Artery Occlusion | Acute Cerebrovascular Accident | Stroke Due to Basilar Artery Occlusion

China
Tasly Biopharmaceuticals Co., Ltd.

Completed

Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)

Acute Ischaemic Stroke

China
Merck Sharp & Dohme LLC

Completed

GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)

Anxiety Disorder
TorreyPines Therapeutics

Completed

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

Sjogren's Syndrome | Xerostomia

United States

Search clinical trials for: time window beyond 4.5 hours

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations